Navigation Links
Approval of Safer Alternative to Pradaxa Delayed by FDA
Date:6/26/2012

Dallas, TX (PRWEB) June 26, 2012

The Pradaxa Resource Center, a patient advocacy group, is alerting patients who have suffered internal bleeding after taking the drug Pradaxa that the release of a safer alternative to the drug has been delayed by an FDA decision.

For now, anyone who has suffered internal bleeding after taking Pradaxa is encouraged to speak with their doctor about their options and to a lawyer about their legal rights as soon as possible.

Pradaxa is an anticoagulant medication prescribed to patients with atrial fibrillation in order to prevent strokes. The Wall Street Journal reported on April 24, 2012, that the drug already reached the $1 billion blockbuster sales mark for the 12-month period ending in February.

Unfortunately, several reports have identified risks with the drug. The FDA warned on December 7, 2011 that it was looking into the safety of Pradaxa after receiving higher than expected reports of injury or death. Most recently, the Institute for Safe Medication Practices reported on June 6, 2012 that Pradaxa led all other medications in 2011 for number of death and bleeding reports to the FDA.

Now, Reuters has reported on June 25th that the FDA is delaying the approval of Eliquis, a rival anticoagulant to Pradaxa developed by Bristol-Myers Squibb Co and Pfizer Inc. According to the article, the new drug will be marketed as a safer alternative to Warfarin since many cardiologists are no longer comfortable prescribing Pradaxa.

Due to the number of people affected by Pradaxa internal bleeding, lawyers have asked that the large number of expected lawsuits be consolidated into one central federal court. The Pradaxa lawsuit is known as Case MDL No. 2385 IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

The Pradaxa Resource Center believes that the consolidation of Pradaxa lawsuits into one court will expedite the litigation process and help victims share in valuable evidence. However, due to the specialized nature of these federal MDL cases, only certain lawyers can help.

Anyone affected by Pradaxa side effects is urged to speak with a lawyer about their legal options. The Pradaxa Resource center works only with lawyers who are already handling Pradaxa lawsuits.

For more information on the research, warnings, pradaxa side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.

Read the full story at http://www.prweb.com/releases/pradaxa/bleeding-lawsuits/prweb9640132.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. U.S. Bests Canada, Europe in Drug Approvals
2. Tafamidis: Approval denotes proven added benefit
3. Human factors researcher pushes for safer gas fireplaces
4. Safer Grilling Methods Might Cut Cancer Risk
5. Planting the right messages may make farms safer
6. OHSU Oregon National Primate Research Center develops new, safer method for making vaccines
7. Safer kidney cancer surgery under-used for poorer, sicker Medicare, Medicaid patients
8. Less-Invasive Surgery for Esophageal Cancer Might Be Safer
9. Study Supports Value of Sigmoidoscopy, an Alternative to Colonoscopy
10. Procedure gives patients with A-fib who cant take blood thinners alternative to reduce stroke
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
Breaking Medicine Technology: